Latest fiscal year 2023 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2023, JRSIS HEALTH CARE CORPORATION reported revenue of $3M, up 101.4% year over year. Operating margin was -5.4% and net margin -2.3%, on a free-cash-flow margin of 14.9% with capital expenditure at 0.0% of revenue. Every figure is computed directly from JRSS's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2023 | $3M | -5.4% | -2.3% |
| FY2022 | $2M | -39.8% | -33.5% |
| FY2021 | $44M | -0.2% | 7.2% |
| FY2020 | $36M | 15.7% | 10.7% |
| FY2019 | $31M | 14.8% | 2.8% |
How does JRSS compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.